COVID-19 VACCINE ROLL OUT : Ministry of Health & Family Welfare.
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Global Landscape: COVID-19 Vaccine Candidates in Clinical Trials
NEGVAC (National Expert Group on Vaccine Administration for COVID-19)
* Constituted on 7 th August 2020, Member (Health) NITI Aayog is chair and Secretary, H&FW is Co-chair * Representation of:
* Relevant ministries of Government of India
* Five State governments viz. Assam, Madhya Pradesh, Maharashtra, Tamil Nadu and Uttar Pradesh
* Technical Experts
* NEGVAC provides guidance on:
* Prioritization of population groups
* Procurement and Inventory management
* Vaccine selection and
* Vaccine delivery and tracking mechanism
Key Considerations During COVID-19 Vaccination Planning
* The COVID-19 vaccination strategy has been formulated as per guidance of NEGVAC.
* Most candidate vaccines follow a 2-dose schedule. - One and three dose schedule for one candidate vaccine each.
* Vaccines are developed using multiple platforms, they are not interchangeable.
* A beneficiary MUST complete vaccination schedule using same vaccine product.
* Storage temperature for most candidate vaccines similar to other UIP vaccines (2⁰ to 8⁰ C)
* Roll-out of vaccine should be done following the election model.
To Read Complete Report & Disclaimer Click Here
Above views are of the author and not of the website kindly read disclaimer
